WS Investor
03 Dec 2025, 09:07
Japan Tobacco Inc. announced that it has completed the transfer of its pharmaceutical business to Shionogi & Co., Ltd. as of December 1, 2025. The move was executed through a company simplified absorption-type split, following agreements announced in May and September 2025.
The divestment marks JT’s full exit from pharmaceuticals as the company sharpens its focus on its core tobacco and processed food businesses. JT, which operates in more than 130 markets and employs about 53,000 people worldwide, said the transfer aligns with its long-term strategy to strengthen value creation across its main business segments.
The divestment marks JT’s full exit from pharmaceuticals as the company sharpens its focus on its core tobacco and processed food businesses. JT, which operates in more than 130 markets and employs about 53,000 people worldwide, said the transfer aligns with its long-term strategy to strengthen value creation across its main business segments.